Sat, Sep 20, 2014, 4:36 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Savient Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • crawfordlong1815 crawfordlong1815 Jan 13, 2011 3:36 PM Flag

    $8 target makes incredible assumptions.

    You are correct in that biotechs lose money due to R and D and no income. However, once the product is approved the burn rate will substantially decrease. If you look at my assumptions you will notice a net margin of 50% so I have accounted to expenses related to marketing, supporting and managing product sales. Insurance companies are very sharp when it comes to approving a treatment or not. They will see how much their current cost of therapy is for a patient, for refract gout it can be very high.

0.00190.0000(0.00%)May 30 3:56 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.